Reuters (8 July 2025) reported that Swiss authorities have approved Coartem Baby, pharmaceutical company Novartis’ first-ever medicine specifically designed to treat malaria in infants weighing less than five kilograms.
Discovery Health criticised the CMS appointed panel's findings as "flawed in methodology" and based on "unscientific assumptions and a misinterpretation of complex data". – Business Day (9 July 2025).
Reacting on the CMS report the Board of Healthcare Funders (BHF), which represents GEMS, Medscheme, and others, rejected the inquiry's conclusions, labelling them "demonstrably and fundamentally flawed." - Business Day (7 June 2025).
The US cuts earlier this year of the President Donald Trump’s Emergency Plan for AIDS Relief (PEPFAR) will result in an annual loss of R7bn in aid to SA’s fight against HIV and Tuberculosis (TB). – Spotlight (4 July 20250)